How to Design a Digital Health Pilot Study

A digital health pilot study earns credibility through six decisions made in order: the endpoint you pick, the baseline you measure first, the sample size the decision requires, the duration long enough to show an effect, consent and data handling that survive scrutiny, and an analysis plan written before you collect a single data point.

Quick Answer: Design the pilot backward from the claim you need to defend and the buyer who will read the results. Choose one primary endpoint that buyer already cares about, measure a real baseline, size the sample to detect a meaningful effect, run long enough to see it, handle consent and data properly, and lock your analysis plan before you collect a single data point.

Most pilots fail before recruitment starts, because nobody wrote down what decision the results were supposed to change. A pilot that measures whatever the product team finds easy to log — sign-ups, session counts, five-star ratings — proves engagement, not efficacy, and buyers who matter can tell the difference immediately. This guide walks through the six decisions that separate a pilot a hospital, payer, or investor will actually credit from one that just generates a nice chart for a pitch deck.

Prerequisites: Know the Claim You're Making and Who Reads the Results

Before you touch a study design template, answer two questions: what claim do you need this pilot to support, and who is the audience that will read the results. The claim sets the endpoint, and the audience sets how rigorous that endpoint has to be. A wellness claim aimed at consumers ("helps you sleep better") tolerates a soft, self-reported outcome; a clinical claim aimed at a health system or payer ("reduces readmissions") does not — and buyer-specific evidence requirements for digital health differ enough that one pilot design can satisfy one audience and get dismissed by another.

Get this ordering wrong and you waste the pilot. Skipping straight to a study protocol without first confirming anyone wants the underlying product is solving the wrong problem well; the sequencing logic belongs upstream, in the complete guide to startup idea validation — demand first, then the evidence that lets validated demand convert into a paying buyer. A pilot isn't where you discover whether people want your product. It's where you prove, to a specific and skeptical reader, that it works.

Step 1: Choose an Endpoint Your Buyer Already Cares About

Pick one primary endpoint that maps directly to a decision your buyer needs to make, and treat every other metric as secondary. A hospital deciding whether to buy your remote monitoring tool cares about readmissions or clinician time saved — not app open rate. A payer cares about cost per member per month. A consumer cares about a symptom they can feel changing. Pick the endpoint that answers their question, not the one your dashboard already tracks.

A pilot needs exactly one primary endpoint, decided before recruitment starts. Splitting attention across five co-equal "primary" outcomes multiplies the chance something moves by chance alone, and leaves you with no clear answer when metrics disagree — three up, two flat is not a result, it's a shrug. Decide what "the pilot worked" means in one sentence, tied to one number, before you write anything else.

Step 2: Establish a Baseline Before You Change Anything

Measure the outcome you care about in the target population before the intervention starts, using the same instrument you'll use afterward. A pilot with no real baseline can show a number moved, but never whether your product moved it.

Comparing your intervention group to itself is the minimum bar; comparing it to nothing is not a pilot, it's a testimonial. Without a documented "before," you can't separate a genuine effect from regression to the mean, seasonal variation, or the observer effect — people simply behave differently while being watched, which inflates almost any pre/post study briefly. Even a single-arm pilot becomes far more credible once you can show the baseline was measured with the same rigor as the outcome, not pulled from an old chart review or an industry average.

If your runway or partner site can support it, add a comparison arm: a matched cohort, a waitlist control, or standard-of-care as usual. It doesn't have to be randomized to be useful — it has to exist. The gap between "outcomes improved" and "outcomes improved more than they would have anyway" is exactly what a sophisticated buyer looks for first.

Step 3: Size Your Sample to the Decision, Not to a Textbook

Size your sample around the smallest effect that would actually change your buyer's decision, not around a number that merely feels credible. A pilot too small to detect a real effect is indistinguishable, on paper, from a pilot where nothing happened.

There is no universal "right" pilot size. The honest process runs backward: decide the smallest improvement that would matter commercially — would a health system act on a 5-point change, or does it need to see 15? — then work out, ideally with a biostatistician, how many participants that requires given the variability you'd expect in that outcome. Defaulting instead to "whatever we can recruit in a quarter" produces pilots underpowered to detect anything but a very large effect, and most real product effects aren't that large.

To illustrate the logic without pretending it's real data: suppose your outcome varies a lot between patients, and a buyer told you a change of roughly 10 points on their preferred measure would be commercially meaningful. A statistician can translate that gap and that variability into a required sample size — this is illustrative reasoning, not a result from any actual pilot, and your own numbers will differ. The point isn't the arithmetic; it's that the conversation has to start from "what decision does this need to support," not a round number that sounded reasonable in a planning meeting.

Step 4: Set a Duration Long Enough to See the Effect

Run the pilot long enough for the behavior or outcome you're measuring to plausibly change and stabilize. A duration chosen around your fundraising calendar instead of around the biology or behavior you're studying is a common way to publish a null result that isn't actually null.

Different endpoints move on different timelines. Engagement and usability signals can appear within weeks; a chronic-disease outcome — blood pressure control, HbA1c, a depression score — typically needs months to show a real, stable change, and measuring too early just adds noise. Match duration to the outcome's natural timeline, then check whether your funding supports it. If it doesn't, narrow the claim to something that shows up faster and defensibly, or find bridge funding rather than truncate the study and overinterpret an early trend.

Build in a defined stopping point and a plan for what happens at it, win or lose. A pilot with no predetermined end date tends to run until the data looks favorable — that's a bias, not a decision.

Step 5: Handle Consent and Data the Way Your Eventual Buyer Will Expect

Run informed consent, data privacy, and security the way a health system's compliance team will eventually audit them — even for an early, informal pilot. Retrofitting consent and data governance after the fact can quietly invalidate results a buyer would otherwise have trusted.

At minimum, that means a clear informed-consent process that tells participants what's being measured and how their data will be used, a data-handling and security posture appropriate to what you're collecting, and — for anything beyond your own team using their own product — independent ethics review through an Institutional Review Board (IRB) or equivalent. Skipping IRB review to move faster is one of the most common ways a pilot becomes unusable later: a health system's legal team will ask, and "we didn't think we needed one" ends the conversation.

This overlaps with the broader diligence a health system runs before they'll even agree to a pilot site, covered in the healthcare pilot readiness checklist — security documentation, business associate agreement (BAA) readiness, and an evidence packet are often prerequisites to getting a pilot, not just to running one. Build that readiness in parallel with your study design, not after you've already been told no.

Step 6: Write Your Analysis Plan Before You Collect Data

Write down your primary endpoint, your comparison method, and what result would count as success or failure before a single participant enrolls. Deciding the analysis after seeing the data is how a null result quietly becomes a favorable one.

Pre-specifying your plan prevents the two most common forms of self-deception in small pilots: cherry-picking which of several measured outcomes to report once you see which one moved, and redefining success after the fact to match whatever result you got. Both are easy to do without noticing under pressure to show traction for a fundraise. A one-page plan — primary endpoint, comparison method, and success threshold, dated before enrollment — is cheap insurance against that pressure.

This is the same discipline The Lean Startup built its build-measure-learn loop around: a pilot only produces validated learning if you decided, in advance, what result would make you pivot and what result would make you persevere. A study designed to confirm a decision you'd already made isn't measurement — it's decoration. Decide what you're testing for before you know the answer, and hold yourself to it once you do.

Comparison: Endpoint Types by Buyer Audience

Different buyers weight different endpoint types, and building a pilot around the wrong one is a fast way to produce a result nobody in the room finds persuasive. The table below maps common endpoint categories to the buyer most likely to find each one credible.

Read the table as a warning as much as a guide: a beautifully executed engagement study will not move a payer, and a clinically rigorous outcome study run on a handful of users will not move an investor evaluating growth. Match the endpoint to the room the results are walking into.

Common Pilot Design Mistakes: Vanity Endpoints and Missing Baselines

The two mistakes that sink the most digital health pilots are choosing an endpoint that's easy to move but doesn't matter to the buyer, and running the study without ever establishing what "before" looked like.

Vanity endpoints are the more seductive mistake because they produce good-looking charts. Downloads, sign-ups, session length, and app-store ratings all tend to move favorably just from running a pilot at all — people who agree to be in a study pay more attention than average users do. None of those numbers answer what a clinical or payer buyer is actually asking, which is whether an outcome changed. If your buyer would shrug at your primary endpoint even doubled, it's a vanity endpoint no matter how real the number is.

Missing baselines are the quieter mistake because they stay invisible until someone asks for the "before" data and it doesn't exist. Teams eager to show progress sometimes start measuring only after the intervention has begun, or substitute a rough population average for a real, matched baseline. Either shortcut makes it impossible to attribute the after-number to your product with confidence — and a buyer's due-diligence team will ask for the baseline before they ask for anything else.

A few smaller, recurring mistakes are worth naming directly:

• Changing the primary endpoint mid-study once it becomes clear the original one won't move — the pilot-study version of moving the goalposts, and sophisticated reviewers watch for it.
• Treating engagement as a proxy for efficacy. High usage proves people like the product; it doesn't prove the product works.
• No predetermined analysis plan, which invites exactly the cherry-picking Step 6 exists to prevent.
• Running the pilot too short to see a real effect, then reporting a null result as conclusive rather than underpowered.

Key Takeaways

• Design backward from the claim and the reader. Decide what you need the pilot to prove and who will judge the result before choosing any method.
• One primary endpoint, decided before recruitment, beats five co-equal metrics that disagree with each other.
• A real baseline is non-negotiable. Without a documented "before," you can't separate your product's effect from regression to the mean, seasonality, or the observer effect.
• Size the sample to the decision, not to convenience. Start from the smallest effect that would change your buyer's mind, then work out the number that detects it.
• Match duration to the outcome's natural timeline, not to your fundraising calendar.
• Consent, IRB review, and data handling done properly the first time are cheaper than retrofitting them after a buyer's compliance team asks.
• Write the analysis plan before you see the data. Pre-specifying your endpoint and success threshold is the single cheapest defense against a favorable-looking null result.

Frequently Asked Questions

What is a good sample size for a digital health pilot study?

There is no fixed number that applies across every pilot. The right size is whatever a statistician calculates from the smallest effect your buyer would consider meaningful and the natural variability of your outcome — a formal calculation, not a round number chosen for convenience. Pilots sized to "whatever fits in a quarter" are frequently too small to detect anything but a very large effect.

How long should a digital health pilot run?

Long enough for your primary outcome to plausibly change and stabilize, which depends on what you're measuring. Usability and engagement signals can appear within weeks; chronic-disease outcomes like blood pressure or depression scores typically need months. Set duration from the outcome's natural timeline first, then check whether your funding supports it — not the other way around.

Do you need IRB approval for a digital health pilot?

Usually yes, once the pilot involves people beyond your own team using their own product. Independent ethics review through an Institutional Review Board protects participants and produces results a health system or payer will trust. Skipping it to move faster is one of the most common reasons a promising pilot becomes unusable later.

What's the difference between a pilot study and a clinical trial?

A pilot study is typically smaller, faster, and often single-arm or loosely controlled — designed to test feasibility and generate an initial signal. A clinical trial, especially a randomized controlled trial, adds a comparison group, a larger sample, and a rigorous protocol designed to establish that an effect is real and attributable to your product, not to chance.